BioSpace News Archive

Biosensors International Announces Enrollment Of First Patient In New U.S. Pivotal BioFreedom Trial – “LEADERS FREE II”

February 15, 2017
·
2 min read
Business

BioInvent Financial Statement 1 January – 31 December 2016

February 15, 2017
·
2 min read
Immuron Significantly Rerated By European/US Analyst’s Report

February 15, 2017
·
1 min read
FDA

FlowAid Medical Tech Snags FDA Clearance for the FA100 SCCD

February 15, 2017
·
2 min read
Oxford Immunotec Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017

February 15, 2017
·
2 min read
Drug Development

Berg Initiates Phase I/II Monotherapy Trial Of BPM 31510-IV In Patients With Glioblastoma Multiforme (GBM)

February 15, 2017
·
4 min read
FDA

The FDA Has Approved Tirosint-SOL, Levothyroxine In Liquid Solution For The American Market, IBSA Patent

February 15, 2017
·
3 min read
Auris Med Announces Proposed Public Offering Of Common Shares And Warrants

February 15, 2017
·
2 min read
Drug Development

Theratechnologies Announces New Data From The Pivotal Phase III Trial Of HIV Monoclonal Antibody And Long-Acting Investigational Antiretroviral Ibalizumab

February 15, 2017
·
9 min read
Drug Development

Merck & Co.’s Doravirine, An Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) For The Treatment Of HIV-1 Infection, Met Primary Efficacy Endpoint In Pivotal Phase III Trial

February 15, 2017
·
7 min read